Virtus ETF Advisers LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 277 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$75,209
-31.5%
2,799
-9.0%
0.05%
-29.2%
Q2 2023$109,726
+40.3%
3,077
-0.0%
0.06%
+51.2%
Q1 2023$78,181
-54.8%
3,078
-27.8%
0.04%
-52.2%
Q4 2022$172,948
+39.5%
4,264
+13.9%
0.09%
+83.7%
Q3 2022$124,000
-5.3%
3,742
+0.6%
0.05%0.0%
Q2 2022$131,000
+26.0%
3,718
+64.7%
0.05%
+4.3%
Q1 2022$104,000
-34.6%
2,258
-5.9%
0.05%
-21.7%
Q4 2021$159,000
+6.0%
2,400
-0.1%
0.06%
-9.1%
Q3 2021$150,000
-28.6%
2,403
-5.0%
0.07%
-23.3%
Q2 2021$210,000
-21.1%
2,530
-36.8%
0.09%
-23.2%
Q1 2021$266,000
-11.9%
4,006
+1.7%
0.11%
-10.4%
Q4 2020$302,000
-25.6%
3,938
-58.2%
0.12%
-41.3%
Q3 2020$406,000
-12.1%
9,424
-12.0%
0.21%
-2.7%
Q2 2020$462,000
+198.1%
10,705
+98.2%
0.22%
+242.2%
Q1 2020$155,000
-60.6%
5,401
-12.8%
0.06%0.0%
Q4 2019$393,000
+42.4%
6,196
-36.7%
0.06%
+14.3%
Q3 2019$276,000
+0.7%
9,785
-5.3%
0.06%
-3.4%
Q2 2019$274,000
-17.7%
10,330
-43.0%
0.06%
-91.8%
Q1 2019$333,000
+32.1%
18,120
-10.6%
0.71%
+1548.8%
Q4 2018$252,000
-66.8%
20,261
-48.8%
0.04%
-44.9%
Q3 2018$758,000
-18.8%
39,546
-42.3%
0.08%
-90.5%
Q2 2018$933,000
+193.4%
68,587
+58.5%
0.82%
+435.7%
Q3 2016$318,000
+38.3%
43,2720.0%0.15%
-9.9%
Q2 2016$230,00043,2720.17%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders